Benchmark has reaffirmed its buy rating on Strategy, setting a price target of $570. This target suggests a potential upside of approximately 515% from the recent closing price of $92.68. The reaffirmation underscores Benchmark's confidence in Strategy's growth prospects.
Benchmark Reaffirms Buy Rating on Strategy with $570 Target
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.
